Invitation
Program
Travel & Hotel
Activities & Tours
Registration
Abstracts
Submit abstract
Links
ISBP Home

Program

A Microsoft Word version of the program can be downloaded at the botton of this page.

Sept 8th, Monday

 
   

8 pm to 9:30 pm

Opening Ceremony: Gala Reception

   

Sept 9th Tuesday

 
   

8 am to 10 am

Seminar I: Oxidative Stress in Uremia:
Important or Epiphenomena?
Co-Chair: Jonathan Himmelfarb, Portland
Co-Chair: Takashi Akiba, Tokyo

The natural history of oxidative stress in renal disease
Jonathan Himmelfarb, Portland

Lessons from animal models
N. Vaziri, Irvine

Is iron a culprit in oxidative stress?
Ziad Massy, Paris

Antioxidant therapy: what is the state of art?
Mona Boaz, Tel-Aviv

   

10 am to 10:15 am

Break

   

10:15 to 11:15 am

10:15 to 12:15 INVITED LECTURE AND FREE COMMUNICATIONS I

Co-Chair: Thomas A. Golper, Nashville

Co-Chair: Robert Zietse, Rotterdam

State of the Art Lecture
Pathogenesis and treatment of renal osteodystrophy
Eduardo Slatopolsky, St. Louis

   

11:15 to 12:15 pm

11:15 to 12:15  FREE COMMUNICATIONS I: MANAGEMENT OF UREMIA

11:15 to 11:30     O 1.  (abstract book # 41)  Application of proteomic techniques to the identification of proteins retained in uremia

Richard A. Ward and Karen Brinkley

University of Louisville, Louisville, Kentucky, USA

11:30 to 11:45     O 2.  (abstract book # 40)  Continuous flow PD (CFPD) as primary renal replacement therapy (RRT) in a patient with hemodialysis access failure
*Richard Amerling MD, *Ilya Glezerman MD, *Amit Nahata MD, *Alan Dubrow MD, **Claudio Ronco MD.

*Division of Nephrology and Hypertension, Beth Israel Medical Center; NY,NY, USA. **Department of Nephrology, St. Bortolo Hospital; Vicenza, Italy

11:45 to 12:00     O 3.  (abstract book # 24)  Medical quality management of hemodialysis affects quality targets for improvement differently
Stoffel, M.P*., Haverkamp, H.§, Lauterbach K.W.,§ Baldamus C.A.*
*Division of Nephrology, University Hospital and § Institute of Health Economics 50924 University of Cologne, Germany

12:00 to 12:15     O 4.  (abstract book # 13)  Iron status in RDT patients on EPO therapy

M. Gonella, G. Calabre, A. Mazzotta, G. Pratesi, G. Vagelli

Renal Unit, General Hospital, Casale, Monferrato, Italy

   

12:15 to 1:30 pm

Lunch break

   

1:30 pm to 3:30 pm

Seminar II: New Approaches to Treating Uremia
Co-Chair: M. Lysaght, Providence
Co-Chair: C. Colton, Cambridge

Dialyzers without membranes
Edward Leonnard, Columbia

Knocking out the barriers to xenotransplantation
Jeff Platt, Rochester

Kidneys from stem cells
Bob Lanza, Worcester

   

3:30 pm to 3:45 pm

Break

   

3:45 pm to 5:45 pm

Seminar III: New aspects of chronic inflammation in ESRD patients
Co-Chair: Charles Dinarello, Denver
Co-Chair: Karl Koch, Hannover

The pathophysiological role of beta-2-microglobulin in uremia: amyloidosis and more?
Gerhard Lonnemann, Hannover

Passage of LPS and non-LPS like cytokine-inducing substances across synthetic dialyzer membranes.
Ralf Schindler, Berlin

Toll like receptors and cytokine production
Kate Fitzgerald, Worcester

Cytokines and joint remodeling
Charles A. Dinarello, Denver

   

5:45 pm to 6:15 pm

ISBP business meeting

   

Sept 10th Wednesday

 
   

8 am to 10 am

Seminar IV: Daily Dialysis
Co-Chair: Robert Lindsay, London, Ontario
Co-Chair: Stanley Shaldon, Monaco

Daily dialysis: overview and observational results
Robert Lindsay, London

Clinical outcome of daily dialysis
Menno Kooistra, Utrecht

Financial considerations in the implementation of daily dialysis
Robert Lockridge, Lynchburg

   

10:00 to 10:15 am

Break

   

10:15 to 11:30 am

10:15 to 12:00 ISBP AWARD SESSION

Co-Chair: Francesco Locatelli

ISBP Award Presentation to Elias Klein

Leif Smeby, Lund

ISBP Award Lecture
"The multidisciplinary approach to develop artificial organs"
Elias Klein, Louisville

   

11:30 to 12:00 pm

11:30 to 12:00  Abstract Awards

11:30 to 11:45        O 5.  (abstract book # 23)  Effect of hemodialysis combined with ultrafiltration on thermal parameters, skin blood flow, and energy expenditure.

FM van der Sande*, LM Rosales#,Z Brenner#, CH Beerenhout*, JP Kooman*,  NW Levin#, RN Greenwood#, D Schneditz**, KML Leunissen*.

Dept of Nephrology*, University Hospital Maastricht, the Netherlands; Renal Research Institute, New York, USA#; Dept of Physiology**, Karl-Franzens University, Graz, Austria.

11:45 to 12:00        O 6.  (abstract book # 51)  Emerging Trends in Survival of ESRD patients with HIV/AIDS associated Nephropathy in USA.

Rasheed A Balogun, MD, Yakup Asarkaya, MA & Ross B Isaacs, MD

Division of Nephrology, University of Virginia, Charlottesville, VA 22908. USA

   

12:00 to 2:15 pm

12:00 to 2:15:  Buffet Lunch and GUIDED POSTER SESSION

3 parallel sessions of poster presentation. Every poster is presented for 5 minutes by the presenting author, followed by 5 minutes of discussion

POSTER SESSION I:                               

Co-Chair: FM van der Sande, Maastricht

Co-Chair: CA Baldamus, Cologne

12:30 to 12:40        P 1.  (abstract book # 19)  Procalcitonin as a new marker of inflammation in comparison to other inflammation markers in diabetic haemodialysis (HD) patients.

G. Visvardis 1, I. Griveas 1, A. Giannakou 2, R. Papadopoulos1, A. Fleva 2, E. Mitsopoulos 1, P. Kyriklidou 1, E. Manou 1, D. Papadopoulou 1, E. Ginikopoulou 1, D. Meimaridou 1, L. Rottstein 1, K. Pavlitou 2, G. Sakellariou 1

1: Nephrology, Papageorgiou General Hospital, Thessaloniki, Greece, 2: Immunology, Papageorgiou General Hospital, Thessaloniki, Greece.

12:40 to 12:50        P 2.  (abstract book # 27)  Relevance of procalcitonin levels in comparison to other markers of inflammation in haemodialysis (HD) patients

G. Visvardis 1, I. Griveas 1, A. Giannakou 2, R. Papadopoulos 1, A. Fleva 2, E. Mitsopoulos1, P. Kyriklidou 1, E. Manou 1, D. Papadopoulou 1, E. Ginikopoulou 1, D. Meimaridou 1, L. Rottstein 1, K. Pavlitou 2, G. Sakellariou 1.
1 Nephrology, Papageorgiou General Hospital, Thessaloniki, Greece, 2 Immunology, Papageorgiou General Hospital, Thessaloniki, Greece.

12:50 to 1:00          P 3.  (abstract book # 48)  Quantitative hepatitis C antibody assay and HCV infection testing algorithm in hemodialysis patients

Jun-ichi Shizuku, Asuka Aoki, Kan Kikuchi, Takaaki Tutui*, Naoko Miwa, Naoki Kimata, Takaumi Yoshida, Toshiaki Suzuki**, Akio Suda***, Takashi Akiba,

Department of Internal Medicine and Blood Purification, Tokyo Women’s Medical University, Hidaka Hospital*, Asagaya Suzuki Clinic**, Suda Clinic***, Tokyo, Japan.

1:00 to 1:10            P 4.  (abstract book # 21)  Impact of left ventricular patterns and diastolic dysfunction on hemodialysis patients

GM Gagliardi, S Rossi, MT Manes*, G Gerace, V Martire, F Caruso, G Vocaturo, N De Napoli.

U.O.Nefrologia,Dialisi e Trapianto-*U.O.Cardiologia-Azienda Ospedaliera di Cosenza (Italy)

1:10 to 1:20            P 5.  (abstract book # 49)  The influence of physical training on exercise capacity, muscle strength and body composition in renal transplant and hemodialysis patients.
E.C.H. van den Ham 1, J.P. Kooman 1, A.M.W.J. Schols 2, J.D. Does 3, M. Akkermans 3, P. Janssen 3, J.P. van Hooff 1.

1: Dept. of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands; 2: Dept. of Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands; 3: Asthma Centre Hornerheide, Horn, The Netherlands.

1:20 to 1:30            P 6.  (abstract book # 14)  Blood pressure modifications in hemodialysis patients

I. Griveas, G. Visvardis, D. Papadopoulou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, L. Rosttein, G. Sakellariou.

Department of Nephrology, Papageorgiou General Hospital, Thessaloniki, Greece

1:30 to 1:40            P 7.  (abstract book # 16)  Blood Pressure (BP) modifications in diabetic hemodialysis (HD) patients in comparison with non-diabetic HD patients

I. Griveas, G. Visvardis, D. Papadopoulou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, L. Rottstein, , G. Sakellariou.

Department of Nephrology, Papageorgiou General Hospital, Thessaloniki, Greece.

1:40 to 1:50            P 8.  (abstract book # 15)  Blood pressure modifications in hemodialysis (HD) patients at the initiation of HD in comparison with long term HD patients.

G. Visvardis, I. Griveas, D. Papadopoulou, E. Mitsopoulos, P. Kyriklidou, E. Manou, D. Meimaridou, E. Ginikopoulou, L. Rosttein, G. Sakellariou.

Department of  Nephrology, Papageorgiou General Hospital, Thessaloniki, Greece

1:50 to 2:00            P 9.  (abstract book # 22)  Dramatic reversal of acute renal failure (ARF) with therapeutic plasma exchange (TPE) in a case of multiple myeloma
N. Sankaranarayanan, A.A. Kaplan and J. Palmisano

Division of Nephrology, University of Connecticut School of Medicine, Farmington, CT  USA.
 
POSTER SESSION II:

Co-Chair: Ralf Schindler, Berlin

Co-Chair: Richard Ward, Louisville

12:30 to 12:40        P 10. (abstract book # 25)  Using Ultrapure Dialysate in Hemodialysis Improves the Erythrocyte Life Span and Erythropoiesis
Yoshiaki Takemoto, Kenji Tsuchida, Tatsuya Nakatani and Taketoshi Kishimoto
Department of Artificial Kidney, Osaka City University Medical School

12:40 to 12:50        P 11.  (abstract book # 29)  The influence of hemodiafiltration on plasma aminothiol redox status

Michal Nowicki, Aneta Czupryniak, *Edward Bald, *Grazyna Chwatko
Dept. of Nephrology and Dialysis, Polish Mother’s Memorial Hospital Research Institute and *Dept. of Environmental Chemistry, University of Lodz, Poland

12:50 to 1:00          P 12. (abstract book # 30)  Size exclusion and tailor made functionalized membranes for elimination of toxins

B. Krause, M. Storr, T. Ertl, R. Deppisch, H. Göhl
Gambro Dialysatoren GmbH und Co. KG, Corporate Research, Holger-Crafoord-Str. 26, D-72379 Hechingen, Germany

1:00 to 1:10            P 13.  (abstract book # 31)  On-line hemodiafiltration (HDF) makes dialysis treatment more tolerable for many patients
L.G. Nilsson, I. Ledebo
Gambro, Lund, Sweden

1:10 to 1:20            P 14.  (abstract book # 52)  Endotoxin permeability of High-Flux hemodialysis membranes fabricated from different polymers

Viktoria Weber 1, Carsten Hornig 2, Sudhir K Bowry 2

1 = Centre for Biomedical Technology, Danube University Krems, 3500 Krems, Austria, 2 = Frensenius Medical Care Deutschland GmbH, 61346 Bad Homburg, Germany

1:20 to 1:30            P 15.  (abstract book # 39)  Clinical comparison of synthetic high flux dialyzers in convective treatments: albumin loss vs. removal of uremic solutes

Marc Souid, Aimé Boula, Nazim Terki-Hassaine
CHI Touladjian, Dialysis Unit, Poissy Cedex, France

1:30 to 1:40            P 16.  (abstract book # 37)  Microencapsulated enzymes for enteral removal of uremic toxins

J.A. O’Loughlin, J.M. Bruder, M.J. Lysaght

Department of Molecular  Pharmacology, Physiology & Biotechnology, Brown University, Providence, RI 02912 USA

1:40 to 1:50            P 17.  (abstract book # 45)  Effect of continuous hemofiltration on severe burned patients-A case series in Vietnam

Tran Ngoc Tuan M.D*, Nguyen Tat Thang M.D,PhD#

*National Institute of Burn Hanoi,Vietnam, #Vietnam - Japan Hemodialysis Center, Transportation Hospital, Hanoi, Vietnam

1:50 to 2:00            P 18.  (abstract book # 38)  Substance transport in albumin dialysis

Christian Steiner, Rajiv Jalan

TERAKLIN AG, Germany

POSTER SESSION III:                      

Co-Chair: Bengt Lindholm, Stockholm

Co-Chair: William R Clark, Indianapolis

12:30 to 12:40        P 19.  (abstract book # 36)  Comparison of treatment results for PD catheter exit-site infections

Mizuya Fukasawa, Nobuaki Tanabe, Masayuki Takeda

Department of Urology, Faculty of Medicine, Interdisciplinary Graduate School of Medical and Engineering, University of Yamanashi, Japan

12:40 to 12:50        P 20.  (abstract book # 55)  Improvement of  Residual Renal Function (RRF) in Diabetic Peritoneal Dialysis (PD) Patients With the Use of Biocompatible PD Fluid: Report of 3 Cases

Marianne Haag-Weber*, Reinhold Deppisch**

*Nephrology, Municipal Hospital, Straubing, Germany, **Corporate Research, Gambro, Hechingen, Germany

12:50 to 1:00          P 21.  (abstract book # 43)  Bacteremia Associated with Tunneled, Cuffed Hemodialysis Catheters (TCC): Wide Disparity in Nephrologist’s Practices and Suboptimal Therapeutic Management
Michele H Mokrzycki H (1), Meilin Zhang (1), Jeffrey Laut (2), John D’Avilla (2), Stuart O Rosenberg (1)
(1) Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, and (2) Hartford Hospital and East Hartford Dialysis, Hartford, CT
 
1:00 to 1:10            P 22.  (abstract book # 56)  Tunneled Cuffed Hemodialysis Catheter (TCC) Bacteremia with Pseudomonas (P): Risk Factors and Outcomes.
Ladan Golestaneh, Stuart O. Rosenberg, Jeffrey Laut, John D'Avella, Michele H. Mokrzycki.
Department of Medicine, Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, N.Y. and Hartford Hospital, Hartford, CT.

1:10 to 1:20            P 23.  (abstract book # 33)  Investigation of cumulative patency rate of native arteriovenous fistulae of chronic hemodialysis patients
Kenji Tsuchida, Yoshiaki Takemoto, Rikio Yoshimura, Masahide Matsuyama Tatsuya Nakatani, Taketoshi Kishimoto
Osaka City University Graduated School of Medicine, Department of Urology and Division of Artificial Kidney


1:20 to 1:30            P 24.  (abstract book # 50)  Percutaneous Native Renal Biopsy: “How Many Passes”?

Rohit Gupta, MD, Yakup Asarkaya, MA & Rasheed A Balogun, MD

Division of Nephrology, University of Virginia, Charlottesville, VA 22908. USA

1:30 to 1:40            P 25.  (abstract book # 35)  Regional Differences in Survival Benefit of HAART in ESRD patients with HIV/AIDS associated Nephropathy (HIVAN) in USA.

Rasheed A Balogun, MD, Yakup Asarkaya, MA & Ross B Isaacs, MD

Division of Nephrology, University of Virginia, Charlottesville, VA 22908. USA

1:40 to 1:50            P 26.  (abstract book # 44)  Increased incidence of hemodialysis catheter infections with intravenous iron administration

Maria Criselda Zaldivar, Smitha Mellacheruvu, Andre A. Kaplan, Nancy D. Adams
University of Connecticut Health Center & UConn Dialysis Center, DCI, Farmington, CT

1:50 to 2:00            P 27.  (abstract book # 32)  Lipid profiles in acidotic and non-acidotic hemodialysis patients

Maria Criselda Zaldivar, M.D., Maricel Pilapil, M.D., and Nancy Day Adams, M.D.;

University of Connecticut Health Center, Farmington, CT

2:10 to 2:15 PRESENTATION OF BEST POSTER AWARD

   

2:15 pm to 3:45 pm

2:15 to 3:45 FREE COMMUNICATIONS II: HEMODIALYSIS AND HEMOFILTRATION: TECHNIQUE AND PHYSIOLOGY

Co-Chair: Ingrid Ledebo, Lund

Co-Chair: Karel Leunissen, Masstricht

2:15 to 2:30            O 7.  (abstract book # 26)  Reduced End-Systolic Elastance Indicating Poor Left Ventricular Contractility in Hemodialysis Patients
E.H.Y. Ie, R. Krams (1), W.B. Vletter (2), F.J. ten Cate (2), R.W. Nette, W. Weimar, R. Zietse.

Departments of Medicine, (1) Experimental Cardiology and (2) Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands

2:30 to 2:45            O 8.  (abstract book # 34)  Barrier function of low and high flux synthetic membranes for endotoxins in contaminated dialysis fluid
T. Ertl, W. Beck, A. Schnell, B. Krause, R. Deppisch, R. Buck, H. Hildwein, H. Göhl
Gambro Corporate Research, Hechingen, Germany

2:45 to 3:00            O 9.  (abstract book # 42)  Impact of high flux hemodialysis using a synthetic membrane on middle molecule levels and markers of cardiovascular risk: results of a prospective cross over study.

Joseph Pitone, Robert Smith, Teresa Koch, Marcia Fogle, Werner Beck, Reinhold Deppisch
Kennedy Dialysis Center, Sewell, NJ, USA; Gambro Corporate Research, Hechingen, Germany
 
3:00 to 3:15            O 10.  (abstract book # 47)  Blood flow rate effects in high-dose pre-dilution CVVH

Z. Huang, W. Zhang, A. Ahuja, R. Rodby, D. Gao, W.R. Clark.

Univ. of Kentucky, Lexington, KY; Rush Medical College, Chicago, IL; NxStage Medical/Indiana Univ., Indianapolis, IN

3:15 to 3:30            O 11.  (abstract book # 53)  Phospate kinetics during alternative hemodialysis treatment regimens:

John K. Leypoldt

VA Salt Lake City Health Care System and University of Utah

3:30 to 3:45            O 12.  (abstract book # 54)  On-line hemofiltration versus hemodialysis at different dialysate temperatures; a short-term hemodynamic study

T. de Jaegere, C. Beerenhout, F. van der Sande, K. Leunissen and J. Kooman.

University Hospital Maastricht, the Netherlands

   

3:45 pm to 4:00 pm

Break

   

4:00 pm to 5:15 pm

00 to 5:15 FREE COMMUNICATIONS III: CHEMICAL MARKERS IN RENAL DISEASE

Co-Chair: Gerhard Lonnemann, Hannover

Co-Chair: Andrew Davenport, London

4:00 to 4:15            O 13.   (abstract book # 17)  The dysfunction of arteriovenous fistulas (AVF) in relation to plasma hemocysteine (HCY) levels of patients undergoing hemodialysis (HD)

P. Kyriklidou, D. Meimaridou, G. Papaioannou, E. Mitsopoulos, E. Manou, G. Visvardis, D. Papadopoulou, E. Ginikopoulou, I. Griveas, R. Papadopoulos, L. Rottstein, G. Sakellariou.

Department of Nephrology and Hematology, Papageorgiou General Hospital, Thessaloniki, Greece

4:15 to 4:30            O 14.   (abstract book # 18)  The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in hemodialysis patients.

Marcelo M. Nascimento a, Mohamed E. Suliman b, Annette Bruchfeld b,

Shirley Y. Hayashi b, Roberto C. Manfro c, Roberto Pecoits-Filho d,

Maria A. Pachaly d, Luciana Renner d, Peter Stenvinkel b, Miguel C.  Riella d, Bengt Lindholm b

a. Faculdade Evangélica de Medicina do Paraná-Brazil  

b. Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science , Karolinska Institutet, Huddinge University Hospital, Stocholm, Sweden

c.Sul-Brazil Post-Graduation Nephrology Program of Universidade Federal do Rio Grande do

d. Pontificia Universidade Catolica do Paraná-Brazil

4:30 to 4:45            O 15.   (abstract book # 20)  Procalcitonin as a new marker of inflammation in elderly haemodialysis (HD) patients

G. Visvardis (1), I. Griveas (1), A. Giannakou (2), A. Fleva (2), E. Mitsopoulos (1), P. Kyriklidou (1), E. Manou (1), D. Papadopoulou (1), E. Ginikopoulou (1), D. Meimaridou (1), A. Pavlitou (2), G. Sakellariou (1).

(1) Department of Nephrology, Papageorgiou General Hospital, Thessaloniki, Greece.

(2) Department of Immunology, Papageorgiou General Hospital, Thessaloniki, Greece.

4:45 to 5:00            O 16.   (abstract book # 28)  Serum cystatin-C concentration as a marker of glomerular filtration rate in patients with and without renal diseases

 G. Visvardis 1, I. Griveas 1, E. Ginikopoulou 1,R. Zilidou 2, E. Mitsopoulos 1, P. Kyriklidou 1, E. Manou 1, D. Papadopoulou 1, D. Meimaridou 1,V. Andreadis 1 , L. Rottstein 1, K Pavlitou 2, G. Sakellariou 1
Departments of Nephrology 1 and Immunology 2, Papageorgiou General Hospital, Thessaloniki ,Greece

5:00 to 5:15            O 17.   (abstract book # 46) The cause of unexplained troponin T elevations in patients with severe renal failure

Jart H.C. Diris*; Jeroen P. Kooman**; Christian M. Hackeng*; Yigal M. Pinto***; Wim Th. Hermens****; Marja P. van Dieijen-Visser*
University Hospital Maastricht, Maastricht, The Netherlands, *department of clinical chemistry, department of nephrology ** and department of cardiology ***; Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands****.

5:15 Closing Remarks and announcement of ISBP 2004

   

7:30 pm -10:00 pm

Farewell Dinner


program.docprogram.docprogram.doc